Fertsy will present its latest research findings at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). This conference, together with the American Society for Reproductive Medicine (ASRM) meeting that Fertsy participated in late last year, are recognized as the two leading global reproductive conferences. The exhibition and scientific sessions will take place from June 29 to July 2, 2025, at the Paris Expo Porte de Versailles in Paris, France. At the exhibition, our company will showcase a comprehensive range of AI technology solutions for assisted reproduction centers at Booth A011.
Meanwhile, following review by the conference scientific committee, an abstract co-authored by Fertsy and the Center for Reproductive Medicine of Nanjing Drum Tower Hospital, titled "Generalization validation of an interpretable artificial intelligence embryo selection model: a Cross-Brand retrospective study", has been accepted for presentation (Abstract Number: P-095). This retrospective internal and external validation study verified the consistency of our AI embryo assessment system, EmbryoInsights, in embryo selection performance across different brands of time-lapse imaging systems (Astec CCM-iBIS vs Vitrolife EmbryoScope). The results showed no significant difference in predictive performance between the two datasets. The study demonstrates that EmbryoInsights, as an interpretable AI system, can effectively adapt to the hardware and software differences between clinical centers and provide consistent assessment results.
We sincerely invite you to visit Booth A011 and experience our technology and products firsthand. You can also read the article on our official WeChat account to learn more about Fertsy and the conference details. Let us exchange ideas and jointly promote the innovation and development of assisted reproductive technology.
